JDEAX Performance — JPMorgan U.S. Research Enhanced Equity Fund, Class A
Data updated: 2026-09-11
JDEAX returned +7.71% year to date and +18.76% over one year to Jun 2026. Annualised returns are +19.09% over 3 years and +12.72% over 5 years. The fund beat its US Large Blend category average: $100 invested three years ago grew to $169, against $157 for the category, and to $119 over one year, against $118. Volatility over the past three years was 12.85% a year. In the 12 months to Jun 2026 the fund lost a net $612.6M, and assets reached $11.83B.
JDEAX Growth of $100
What $100 invested in JPMorgan U.S. Research Enhanced Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | JDEAX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $119 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $169 | $157 |
| 5 years (Jul 2021 – Jun 2026) | $182 | $161 |
| Since data start (Jul 2019 – Jun 2026) | $283 | $229 |
JDEAX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.71% |
| 1 year | +18.76% |
| 3 years (annualised) | +19.09% |
| 5 years (annualised) | +12.72% |
JDEAX Annual Returns
Calendar-year total returns of JPMorgan U.S. Research Enhanced Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +7.71% |
| 2025 | +16.27% |
| 2024 | +24.30% |
| 2023 | +27.91% |
| 2022 | −18.36% |
| 2021 | +30.16% |
| 2020 | +20.37% |
| 2019 (Jul–Dec) | +11.13% |
JDEAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.2% | −0.9% | −5.2% | +10.2% | +4.2% | −1.4% | — | — | — | — | — | — |
| 2025 | +2.1% | −1.1% | −5.8% | −1.1% | +6.3% | +5.3% | +2.2% | +2.0% | +3.2% | +1.9% | +0.3% | +0.2% |
| 2024 | +1.8% | +5.4% | +3.3% | −3.8% | +5.0% | +3.7% | +0.9% | +2.5% | +1.9% | −0.7% | +5.3% | −2.8% |
| 2023 | +6.5% | −2.2% | +3.7% | +1.8% | +0.6% | +6.6% | +3.3% | −1.3% | −4.6% | −2.0% | +9.0% | +4.5% |
| 2022 | −4.8% | −2.9% | +3.3% | −8.7% | +0.2% | −8.4% | +9.5% | −4.1% | −9.2% | +7.5% | +5.9% | −6.1% |
| 2021 | −0.7% | +2.7% | +4.8% | +5.7% | +0.6% | +2.3% | +2.4% | +2.7% | −4.9% | +7.6% | −0.5% | +4.5% |
| 2020 | +0.1% | −7.8% | −12.8% | +13.3% | +5.0% | +2.4% | +5.9% | +7.8% | −4.3% | −2.7% | +11.1% | +3.9% |
| 2019 | — | — | — | — | — | — | +1.3% | −2.1% | +2.0% | +2.5% | +3.8% | +3.3% |
JDEAX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 12.85%
- 3-year Sharpe ratio: 1.14 (vs 4.5% risk-free rate)
- Best month: +10.22% (Apr 2026)
- Worst month: −5.77% (Mar 2025)
JDEAX Fund Flows
Monthly money in and out of JPMorgan U.S. Research Enhanced Equity Fund, from SEC Form N-PORT.
- 12-month net flow: −$612.6M
- 12-month gross sales (incl. reinvestments): $2.7B
- Sales ÷ redemptions: 0.82×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $246.0M | $178.0M | $68.0M |
| May 2026 | $422.2M | $309.3M | $112.8M |
| Apr 2026 | $207.9M | $216.2M | −$8.4M |
| Mar 2026 | $327.7M | $476.4M | −$148.6M |
| Feb 2026 | $164.4M | $108.3M | $56.0M |
| Jan 2026 | $128.6M | $670.4M | −$541.8M |
| Dec 2025 | $725.1M | $469.2M | $255.8M |
| Nov 2025 | $87.9M | $172.3M | −$84.4M |
| Oct 2025 | $99.2M | $147.8M | −$48.5M |
| Sep 2025 | $143.0M | $152.4M | −$9.4M |
| Aug 2025 | $82.3M | $269.7M | −$187.4M |
| Jul 2025 | $104.1M | $180.9M | −$76.8M |
JDEAX Assets Under Management
Net assets of JPMorgan U.S. Research Enhanced Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $11.83B |
| 2026-03-31 | $10.30B |
| 2025-12-31 | $11.48B |
| 2025-09-30 | $11.60B |
| 2025-06-30 | $11.07B |
| 2025-03-31 | $10.04B |
| 2024-12-31 | $10.27B |
| 2024-09-30 | $10.36B |
| 2024-06-30 | $9.44B |
| 2024-03-31 | $9.13B |
| 2023-12-31 | $7.73B |
| 2023-09-30 | $7.04B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.